Department of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, United Kingdom,
Centre for Health Research and Innovation, National Institute of Health Research Lancashire Clinical Research Facility, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, United Kingdom,
Nephron. 2019;141(3):147-155. doi: 10.1159/000494223. Epub 2018 Dec 14.
BACKGROUND/AIMS: Frail patients with chronic kidney disease (CKD) have an increased hospitalisation and mortality rate. However, many popular frailty screening methods have not been validated in patients with CKD. This study evaluates the diagnostic accuracy of several frailty screening methods in patients with CKD G4-5 and those established on haemodialysis (G5D).
Ninety participants with CKD G4-5D were recruited from Nephrology Outpatient Clinics and 2 Haemodialysis Units between December 2016 and December 2017. Frailty was diagnosed using the Fried Frailty Phenotype. The following frailty screening tests were evaluated: Clinical Frailty Scale, PRISMA-7, CKD Frailty Index, CKD FI-LAB, walking speed, hand grip strength and Short Physical Performance Battery.
The mean age of participants was 69 years (SD ±13). One-third of participants were dialysis-dependent. Nineteen (21%) patients were categorised as frail, 42 (47%) as pre-frail and 29 (32%) as robust. Overall, walking speed was the most discriminative measure (AUC 0.97 [95% CI 0.93-1.00], sensitivity 0.84 [95% CI 0.62-0.94], specificity 0.96 [95% CI 0.88-0.99]). The Clinical Frailty Scale had the best performance of the non-physical assessment frailty screening methods (AUC 0.90 [95% CI 0.84-0.97], sensitivity 0.79 [95% CI 0.57-0.91], specificity 0.87 [95% CI 0.78-0.93]).
Walking speed can be used to accurately screen for frailty in CKD populations. If it is not practical to perform a physical assessment to screen for frailty, the Clinical Frailty Scale is a useful alternative.
背景/目的:患有慢性肾脏病(CKD)的虚弱患者住院率和死亡率较高。然而,许多流行的虚弱筛查方法尚未在 CKD 患者中得到验证。本研究评估了几种在 CKD G4-5 患者和接受血液透析(G5D)的患者中进行的虚弱筛查方法的诊断准确性。
2016 年 12 月至 2017 年 12 月期间,从肾脏病门诊和 2 个血液透析单位招募了 90 名患有 CKD G4-5D 的参与者。使用 Fried 虚弱表型诊断虚弱。评估了以下虚弱筛查测试:临床虚弱量表、PRISMA-7、CKD 虚弱指数、CKD FI-LAB、步行速度、握力和简短身体表现电池。
参与者的平均年龄为 69 岁(SD ±13)。三分之一的参与者依赖透析。19 名(21%)患者被归类为虚弱,42 名(47%)为虚弱前期,29 名(32%)为健壮。总体而言,步行速度是最具鉴别力的指标(AUC 0.97 [95% CI 0.93-1.00],敏感性 0.84 [95% CI 0.62-0.94],特异性 0.96 [95% CI 0.88-0.99])。临床虚弱量表在非身体评估虚弱筛查方法中表现最佳(AUC 0.90 [95% CI 0.84-0.97],敏感性 0.79 [95% CI 0.57-0.91],特异性 0.87 [95% CI 0.78-0.93])。
步行速度可用于准确筛查 CKD 人群的虚弱。如果进行身体评估以筛查虚弱不切实际,则临床虚弱量表是一种有用的替代方法。